Venous Thromboembolism VTE Prophylaxis at Cesarean Section - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Venous Thromboembolism VTE Prophylaxis at Cesarean Section

Description:

Review the epidemiology of venous thromboembolism ... 'Strangulation' with GCS. Cost of Mechanical Devices. Device. Cost. PCD. Foot $61.54. Foot Reprocessed ... – PowerPoint PPT presentation

Number of Views:102
Avg rating:3.0/5.0
Slides: 21
Provided by: thoma62
Category:

less

Transcript and Presenter's Notes

Title: Venous Thromboembolism VTE Prophylaxis at Cesarean Section


1
Venous Thromboembolism (VTE) Prophylaxis at
Cesarean Section
  • Phillip N. Rauk, MD

2
Surgical Care Improvement Project (SCIP Measures)
  • Infection
  • Cardiac
  • Venous Thromboembolism
  • Process Measures
  • Prophylaxis ordered
  • Prophylaxis received 24 hrs before to 24 hrs
    after surgery
  • Outcome Measures
  • PE (and DVT) diagnosed during hospitalization and
    within 30 days of surgery
  • Respiratory

3
Objectives
  • Review the epidemiology of venous thromboembolism
    (VTE) in pregnancy
  • Relate the pregnancy specific risks to
    nonpregnant patient population
  • Discuss prophylaxis options

4
Scope of the Problem
  • VTE risk is increased in pregnancy and postpartum
    3-5 fold
  • VTE is 3-10 fold higher after CS than vaginal
    delivery
  • Pulmonary embolism (PE) - leading cause of
    maternal mortality in the 90s accounting for 20
    of deaths
  • VTE Mortality rate 1.1/100,000 deliveries in
    2000-2001
  • No pregnancy specific data related to prophylaxis
    in most situations
  • Recommendations are extrapolated from
    non-pregnant populations

CDC 2003, James 2005
5
VTE Risk Factors
  • Prior VTE
  • Thrombophilia
  • Cancer
  • Age gt40 yrs
  • Obesity (BMIgt30)
  • Tobbacco
  • Estrogen Therapy
  • Chronic Medical Disease
  • Systemic Infection
  • Vericose Veins
  • Multiparity (gt4)
  • Immobilization
  • Bedrest
  • Preeclampsia
  • Postpartum Hemorrhage
  • Cesarean Section

6
Natural History of DVT Related to Surgery
  • Majority develop in the calf during surgery
  • 50 will resolve spontaneously within 72 hours
  • 15 with extend into proximal veins
  • 80 of symptomatic DVT involve proximal veins
    (majority of calf vein DVTs are asymptomatic)
  • 50 in proximal veins will result in symptomatic
    pulmonary embolus
  • 40-50 of proximal DVT have asymptomatic PE
  • 10 of PEs are fatal within one hour of symptoms

Kearon, 2003
7
Timing of DVT
8
Incidence of VTE
Samama, 2006 ACCP, 2008
without prophylaxis
9
Prophylaxis Based on Risk
ACCP, 2008
10
VTE Incidence
Greer, 1999
11
Risks of Heparin Prophylaxis
  • Severe bleeding
  • Incidence - 1/1000
  • Heparin-induced thrombocytopenia (HIT)
  • Incidence 1 probably lower in pregnancy
  • Thrombosis develops (arterial or venous) in 30-50

Collins, 1988
Arepally, 2006
12
VTE Associated with Cesarean Section
  • the risk of VTE is higher after CS than after
    vaginal delivery. The presence of additional
    risk factors may exacerbate this risk. It has
    been recommended that GCS be used during and
    after cesarean section in patients at moderate
    risk and heparin prophylaxis be added in those
    at high risk. However there is insufficient
    data to provide information as to the benefits
    with these interventions.

ACCP 2004
13
ACCP Cesarean Section Prophylaxis Recommendation
  • without additional risk factors we recommend
    against the use of specific thromboprophylaxis
    other than early mobilization (Grade 1B)
  • in the presence of at least one additional risk
    factor pharmacologic thromboprophylaxis or
    mechanical prophylaxis while in hospital
    recommended. (Grade 2C)

ACCP 2008
14
Pneumatic Compression Device Prophylaxis for
Cesarean Section
Incidence per 10,000 Cesarean Sections
Quinones, 2005
15
Pneumatic Compression Device Prophylaxis for
Cesarean Section
  • Cost effective with following assumptions
  • Incidence of DVT gt 6.8/1000
  • 75 are asymptomatic
  • DVT reduced gt 50
  • Cost of PCD lt 180

Casele, 2006
16
Graded Compression Stockings
Amaragiri, Cochrane Collaboration, 1999
17
Limitations of Mechanical Devices
  • Compliance
  • Both GCS and PCD removed due to discomfort
  • Improper fit
  • Strangulation with GCS

18
Cost of Mechanical Devices
19
(No Transcript)
20
Summary
  • Objective data to guide VTE prophylaxis for CS is
    very limited
  • In the absence of data First do no Harm
  • Individualize heparin therapy and reserve it for
    the highest risk patients previous VTE,
    thrombophilia, multiple risk factors (elderly
    gravida, obese, severe preeclampsia, at bed rest)
  • Early ambulation alone is acceptable and
    recommended for many CS patients
  • GCS or PCD are acceptable and may be cost
    effective
Write a Comment
User Comments (0)
About PowerShow.com